Matches in SemOpenAlex for { <https://semopenalex.org/work/W4381377427> ?p ?o ?g. }
Showing items 1 to 62 of
62
with 100 items per page.
- W4381377427 abstract "Introduction: Understanding the health impacts of socioeconomic deprivation (SED) and its interaction with type 2 diabetes is important for patient care and effective public health initiatives. Large-scale proteomic profiling using aptamer-based technology to measure 7,000 proteins has facilitated the development of blood-based proteomic signatures for 10 cardiometabolic SomaSignal Tests (SST), including a test that predicts the 4-year risk of a cardiovascular event (CV risk). Methods: The cross-sectional PsoBid study recruited participants from socioeconomically deprived and affluent areas of Glasgow, Scotland with similar age ranges and equal proportions of male and female, to identify relevant health disparities. We used regression analyses to estimate the association between SSTs and socioeconomic status (affluent (n = 257, 50.7%), deprived (n = 250, 49.3%)) and prevalent diabetes (n = 27 (5.3%), 7 (2.7%) affluent, 20 (8.0%) SV). Results: Diabetes was associated with SST predicted increased visceral fat, lean body mass, liver fat, body fat percentage, resting energy rate, and CV risk score, and worse proteomic predictors of cardiorespiratory fitness, glucose tolerance, alcohol impact, and kidney health (p<0.05). SED was associated with SST predicted increased visceral adiposity and CV risk score, and decreased cardiorespiratory fitness, glucose tolerance, and kidney health (p<0.05). The association between diabetes and CV risk score was highest among socioeconomically deprived participants (interaction p-value: 0.01). Conclusion: These results demonstrate that participants with diabetes and SED have proteomic phenotypes consistent with decreased cardiometabolic health compared to participants without diabetes or SV and SED is associated with worse predicted cardiovascular risk in patients with diabetes. Proteomics may be useful in identifying and monitoring the health effects of diabetes and SED or the impact of relevant interventions. Disclosure M.Simpson: Employee; SomaLogic Operating CO., Inc. R.Ostroff: Employee; SomaLogic. S.A.Williams: Employee; SomaLogic. N.Sattar: Advisory Panel; Amgen Inc., Boehringer Ingelheim and Eli Lilly Alliance, Novartis, Roche Diagnostics, Consultant; Afimmune Limited, Hanmi Pharm. Co., Ltd., Pfizer Inc., Other Relationship; Abbott, AstraZeneca, Boehringer Ingelheim Pharma GmbH&Co.KG, Eli Lilly and Company, Janssen Pharmaceuticals, Inc., Novo Nordisk, Sanofi, Research Support; AstraZeneca, Boehringer Ingelheim Pharma GmbH&Co.KG, Novartis, Roche Diagnostics." @default.
- W4381377427 created "2023-06-21" @default.
- W4381377427 creator A5009028601 @default.
- W4381377427 creator A5038534789 @default.
- W4381377427 creator A5041877631 @default.
- W4381377427 creator A5078498803 @default.
- W4381377427 date "2023-06-20" @default.
- W4381377427 modified "2023-09-24" @default.
- W4381377427 title "1237-P: Proteomic Indicators of Metabolic Health in Diabetes and Social Vulnerability" @default.
- W4381377427 doi "https://doi.org/10.2337/db23-1237-p" @default.
- W4381377427 hasPublicationYear "2023" @default.
- W4381377427 type Work @default.
- W4381377427 citedByCount "0" @default.
- W4381377427 crossrefType "journal-article" @default.
- W4381377427 hasAuthorship W4381377427A5009028601 @default.
- W4381377427 hasAuthorship W4381377427A5038534789 @default.
- W4381377427 hasAuthorship W4381377427A5041877631 @default.
- W4381377427 hasAuthorship W4381377427A5078498803 @default.
- W4381377427 hasConcept C117437137 @default.
- W4381377427 hasConcept C126322002 @default.
- W4381377427 hasConcept C134018914 @default.
- W4381377427 hasConcept C144024400 @default.
- W4381377427 hasConcept C147077947 @default.
- W4381377427 hasConcept C149923435 @default.
- W4381377427 hasConcept C2777180221 @default.
- W4381377427 hasConcept C2780221984 @default.
- W4381377427 hasConcept C2908647359 @default.
- W4381377427 hasConcept C555293320 @default.
- W4381377427 hasConcept C71924100 @default.
- W4381377427 hasConcept C74909509 @default.
- W4381377427 hasConcept C99454951 @default.
- W4381377427 hasConceptScore W4381377427C117437137 @default.
- W4381377427 hasConceptScore W4381377427C126322002 @default.
- W4381377427 hasConceptScore W4381377427C134018914 @default.
- W4381377427 hasConceptScore W4381377427C144024400 @default.
- W4381377427 hasConceptScore W4381377427C147077947 @default.
- W4381377427 hasConceptScore W4381377427C149923435 @default.
- W4381377427 hasConceptScore W4381377427C2777180221 @default.
- W4381377427 hasConceptScore W4381377427C2780221984 @default.
- W4381377427 hasConceptScore W4381377427C2908647359 @default.
- W4381377427 hasConceptScore W4381377427C555293320 @default.
- W4381377427 hasConceptScore W4381377427C71924100 @default.
- W4381377427 hasConceptScore W4381377427C74909509 @default.
- W4381377427 hasConceptScore W4381377427C99454951 @default.
- W4381377427 hasIssue "Supplement_1" @default.
- W4381377427 hasLocation W43813774271 @default.
- W4381377427 hasOpenAccess W4381377427 @default.
- W4381377427 hasPrimaryLocation W43813774271 @default.
- W4381377427 hasRelatedWork W1966504330 @default.
- W4381377427 hasRelatedWork W1974041167 @default.
- W4381377427 hasRelatedWork W1979139803 @default.
- W4381377427 hasRelatedWork W1991448037 @default.
- W4381377427 hasRelatedWork W2037631372 @default.
- W4381377427 hasRelatedWork W2040058909 @default.
- W4381377427 hasRelatedWork W2132898409 @default.
- W4381377427 hasRelatedWork W2142644183 @default.
- W4381377427 hasRelatedWork W2171462316 @default.
- W4381377427 hasRelatedWork W2748952813 @default.
- W4381377427 hasVolume "72" @default.
- W4381377427 isParatext "false" @default.
- W4381377427 isRetracted "false" @default.
- W4381377427 workType "article" @default.